If you have insurance through work and your depression has not budged on the usual medications, you have probably started hearing about newer options. You have also probably started wondering which of them are FDA-approved and what your plan will actually do about them. This FAQ answers the questions we hear most often from people in exactly that spot.

Several answers draw on our own poll of 443 Midwest adults, and its figures are the final, validated ones.

Do other people really weigh FDA approval this much?

Yes. Asked how FDA approval would figure in trying a new depression treatment, 19 percent of respondents called it decisive and another 40 percent called it big. Just 14 percent gave it no weight. Respondents with commercial coverage, 173 of them, put the combined share at 54 percent. Most people treat approval as a meaningful signal.

Which newer depression treatments are FDA-approved?

In the ketamine family, only esketamine, the Spravato nasal spray, carries FDA approval for depression, specifically adult depression that other treatment has not relieved, and patients use the spray inside a certified clinic. Brain Recovery Centers outlines how Spravato treatment works. TMS, which uses magnetic pulses, holds device clearance from the FDA for depression antidepressants have not helped. Prescribing IV ketamine against depression is off-label, while at-home ketamine products hold no FDA approval for depression at all.

I've never heard of Spravato. Is that strange?

Not at all. Of everyone we surveyed, 73 percent had never encountered it. Another 21 percent knew only the name, so a mere 6 percent could explain it.

What does "certified setting" mean for me?

Esketamine is part of a federal safety program because of side effects like sedation, dissociation, and increases in blood pressure. Only healthcare settings certified under that program may give it. You use the spray yourself while staff watch, then remain on site for two or more hours. Driving waits until the following day and a night of sleep, so line up a ride.

Does FDA approval mean my employer plan will cover it?

Not automatically. Your plan makes its own coverage decisions. For esketamine, most commercial plans require prior authorization, which typically means your doctor documents a diagnosis of treatment-resistant depression and the antidepressants you have already tried. Some plans also have step therapy rules or require a specific provider network.

What approval usually gives you is a defined path to coverage, which off-label treatments often lack.

Is it a medical benefit or a pharmacy benefit?

It depends on your plan, and it matters for what you pay. Some plans have the clinic buy the drug and bill it under the medical benefit. Others require the drug to come through a specialty pharmacy and be shipped to the clinic. Either way, the monitored office visit is usually billed separately. Ask member services which applies to you.

Is there help with costs?

The manufacturer of esketamine offers a savings program for eligible patients with commercial insurance. Programs like this generally do not apply to Medicare or Medicaid. Ask the clinic whether the program covers only the medication or some of the visit costs too, and what your share would be after it applies.

Why isn't IV ketamine covered by my plan?

Many commercial plans do not cover IV ketamine for depression because that use is off-label. The FDA approved ketamine as an anesthetic, not for depression. Some plans may cover parts of the visit. Many patients pay for infusions out of pocket. If you are considering it, ask the clinic for a written price and ask your plan directly.

What about at-home ketamine?

At-home products, often compounded lozenges or tablets, have no FDA approval for depression, and the agency has flagged the dangers of compounded ketamine taken unsupervised. They are generally not covered by commercial plans. They are also a very different thing from supervised esketamine, and it is important not to confuse the two.

How much does insurance usually matter to people in these decisions?

A great deal. Of our respondents, 85 percent put insurance coverage among the two provider qualities they valued most. Given a tradeoff between a covered option with more hoops and a simpler self-pay route, 51 percent picked coverage.

What if my plan denies it?

Get the denial reason on paper. Many cite missing documentation your doctor can supply. An internal appeal is your right, and an independent external review usually follows if needed. Federal parity rules also generally require that mental health benefits not be harder to use than comparable medical benefits.

Does the timing of my plan year matter?

It can. Many employer plans reset deductibles on January 1, though some run on a different calendar. A treatment that starts twice a week and continues for months will likely cross into a new plan year at some point, which can change your share midway. If you have a health savings account or flexible spending account, ask whether treatment costs qualify, and check how much is left in the account before you begin.

What should I bring to the first call with my plan?

Your member ID, the name of the treatment, the name and location of the clinic, and ideally the billing codes the clinic expects to use. Write down the date, the representative's name, and a reference number for the call. If you are told something is covered, ask them to point you to the policy in writing.

Who should I talk to first?

Your own doctor or psychiatrist. Our respondents would mostly begin there, with 56 percent choosing a primary doctor and 23 percent a psychiatrist. A clinician can confirm whether your history matches the approved use, which is the first thing your plan will want to know.

Does this replace a doctor?

No. It is general information about FDA status and commercial coverage. Fit is for a clinician familiar with your history to judge, and no treatment can promise results.

If your employer plan questions feel small next to thoughts of ending your life, please call or text 988 right away. Help from the Suicide and Crisis Lifeline is free, private, and open through every night and weekend.

Methodology

This employer-plan FAQ leans on a Pollfish consumer panel survey that stayed open until June 23, 2026, drawing 443 adult participants aged 18 to 64 from Wisconsin, Missouri, Iowa, Nebraska, Oklahoma, Kansas, Indiana, Ohio, Illinois, and Minnesota. Figures are final after Pollfish's validation; only the commercial group is broken out. Our publisher commissioned that research and covered what it cost.